Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Relmada Therapeutics (RLMD) Invested Capital (2016 - 2026)

Relmada Therapeutics has reported Invested Capital over the past 3 years, most recently at -$31155.0 for Q1 2014.

  • Quarterly Invested Capital fell 1623.17% to -$31155.0 in Q1 2014 from the year-ago period, while the trailing twelve-month figure was -$31155.0 through Feb 2014, down 1623.17% year-over-year, with the annual reading at -$13657.0 for FY2013, 220.24% down from the prior year.
  • Invested Capital was -$31155.0 for Q1 2014 at Relmada Therapeutics, down from -$28031.0 in the prior quarter.
  • Over five years, Invested Capital peaked at $11358.0 in Q3 2012 and troughed at -$31155.0 in Q1 2014.
  • The 3-year median for Invested Capital is -$17475.0 (2013), against an average of -$14097.7.
  • Year-over-year, Invested Capital tumbled 220.24% in 2013 and then tumbled 1623.17% in 2014.
  • A 3-year view of Invested Capital shows it stood at $11358.0 in 2012, then plummeted by 346.8% to -$28031.0 in 2013, then dropped by 11.14% to -$31155.0 in 2014.
  • Per Business Quant, the three most recent readings for RLMD's Invested Capital are -$31155.0 (Q1 2014), -$28031.0 (Q4 2013), and -$13657.0 (Q3 2013).